These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9067305)

  • 1. DynorphinA-(2-17) restores spinal/supraspinal morphine synergy in morphine-tolerant mice.
    He L; Lee NM
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1210-4. PubMed ID: 9067305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine antinociception in different strains of mice: relationship of supraspinal-spinal multiplicative interaction to tolerance.
    Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1988 Nov; 247(2):603-8. PubMed ID: 3183956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinal antinociceptive synergism between morphine and clonidine persists in mice made acutely or chronically tolerant to morphine.
    Fairbanks CA; Wilcox GL
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1107-16. PubMed ID: 10027848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways.
    Wigdor S; Wilcox GL
    J Pharmacol Exp Ther; 1987 Jul; 242(1):90-5. PubMed ID: 3612540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine.
    Yeung JC; Rudy TA
    J Pharmacol Exp Ther; 1980 Dec; 215(3):633-42. PubMed ID: 6893721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Centrally administered bombesin affects gastrointestinal transit and colonic bead expulsion through supraspinal mechanisms.
    Koslo RJ; Burks TF; Porreca F
    J Pharmacol Exp Ther; 1986 Jul; 238(1):62-7. PubMed ID: 3755171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone produces protracted tolerance in mice treated with a single dose of morphine.
    Sofuoglu M; Takemori AE
    J Pharmacol Exp Ther; 1990 Sep; 254(3):836-40. PubMed ID: 2395115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic coadministration of chloramphenicol with intravenous but not intracerebroventricular morphine markedly increases morphine antinociception and delays development of antinociceptive tolerance in rats.
    Smith MT; Nielsen CK; Lim-Fraser MY; Wright AW; Lau M
    Drug Metab Dispos; 2000 Feb; 28(2):236-44. PubMed ID: 10640523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of cross-tolerance to the antinociceptive effects of systemic and topical cannabinoids in morphine-tolerant mice.
    Yeşilyurt O; Dogrul A
    Neurosci Lett; 2004 Nov; 371(2-3):122-7. PubMed ID: 15519741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nitric oxide/cyclic GMP system at the supraspinal site is involved in the development of acute morphine antinociceptive tolerance.
    Xu JY; Hill KP; Bidlack JM
    J Pharmacol Exp Ther; 1998 Jan; 284(1):196-201. PubMed ID: 9435178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antinociceptive synergism between supraspinal and spinal sites after subcutaneous morphine evidenced by CNS morphine content.
    Miyamoto Y; Morita N; Kitabata Y; Yamanishi T; Kishioka S; Ozaki M; Yamamoto H
    Brain Res; 1991 Jun; 552(1):136-40. PubMed ID: 1913173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supraspinally administered agmatine prevents the development of supraspinal morphine analgesic tolerance.
    Kitto KF; Fairbanks CA
    Eur J Pharmacol; 2006 Apr; 536(1-2):133-7. PubMed ID: 16546161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
    Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
    Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal substance P augments morphine-induced antinociception: possible relevance in the production of substance P N-terminal fragments.
    Komatsu T; Sasaki M; Sanai K; Kuwahata H; Sakurada C; Tsuzuki M; Iwata Y; Sakurada S; Sakurada T
    Peptides; 2009 Sep; 30(9):1689-96. PubMed ID: 19520130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulators of pain in the spinal cord.
    Jen MF; Lu CH; Huang L; Han JS
    NIDA Res Monogr; 1986; 75():457-60. PubMed ID: 2893278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserum.
    Bian D; Ossipov MH; Ibrahim M; Raffa RB; Tallarida RJ; Malan TP; Lai J; Porreca F
    Brain Res; 1999 Jun; 831(1-2):55-63. PubMed ID: 10411983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antinociceptive effect of morphine is reversed by okadaic acid in morphine-naive but not in morphine-tolerant mice.
    Ocaña M; Entrena JM; Baeyens JM; Del Pozo E
    Pharmacol Biochem Behav; 2007 Jan; 86(1):21-6. PubMed ID: 17234262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5.
    Hua XY; Hayes CS; Hofer A; Fitzsimmons B; Kilk K; Langel U; Bartfai T; Yaksh TL
    J Pharmacol Exp Ther; 2004 Feb; 308(2):574-82. PubMed ID: 14610237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine protease inhibitors suppress the development of tolerance to morphine antinociception.
    Tan-No K; Shimoda M; Sugawara M; Nakagawasai O; Niijima F; Watanabe H; Furuta S; Sato T; Satoh S; Arai Y; Kotlinska J; Silberring J; Terenius L; Tadano T
    Neuropeptides; 2008 Jun; 42(3):239-44. PubMed ID: 18440066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.